Clinical trialPhase 2Completed
FOLFIRINOX + RT for Pancreatic Cancer
Phase II Study of Preoperative FOLFIRINOX Followed by Accelerated Short Course Radiation Therapy for Borderline-Resectable Pancreatic Cancer
- Outcome
- Outcome unknown
- Phase
- Phase 2
- Status
- Completed
- Study type
- Interventional
- Start
- 2 August 2012
- Expected end
- 15 April 2021
- Enrollment
- 48 participants
- Sites
- 1
- Primary outcomes
- Rate of R0 Resection
- Sponsor
- Other
- Results posted
- 2018-04-30
- Last update
- 4 September 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try